Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(PWRM, GILD, BGBV, SVVS, WSFS) Stock in Action by Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

power3 Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Alzheimer's disease (AD) is a slowly progressive disease of the brain that is characterized by impairment of memory and eventually by disturbances in reasoning, planning, language, and perception. The likelihood of having Alzheimer's disease increases substantially after the age of 70 and may affect around 50% of persons over the age of 85. Nonetheless, Alzheimer's disease is not a normal part of aging and is not something that inevitably happens in later life. For example, many people live to over 100 years of age and never develop Alzheimer's disease.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

***********

Gilead Sciences, Inc. (Nasdaq:GILD) is pleased to announced that Kevin Young, Executive Vice President of Commercial Operations, has been appointed a Commander of The British Empire, one of Great Britain's highest civilian honors, in recognition of his "services to the healthcare and pharmaceutical industries, particularly to the development and marketing of life-changing medicines."

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. The company was founded in 1987 and is headquartered in Foster City, California.

******************

bgbv_logo_200x72 Blue Gold Beverages, Inc. (OTC:BGBV)

Blue Gold Beverages, Inc. (OTC:BGBV) is pleased to announce its wholly owned subsidiary EPIC Nutrition, Inc. has signed an exclusive distribution agreement with Contemporary Marketing, Inc. ("CMI") one of the leading National Sales and Marketing companies in the USA. The agreement provides for CMI to be the exclusive broker for EPIC's NRG™, Goodnight™ and COLDsense™ brands for key retailers Walgreens, CVS, Target, GNC and Stop & Shop resulting in thousands of potential points of distribution at these retail outlets.

CMI will spearhead the new product launches of EPIC's new NRG Pro-N-Go™, a nationally branded energy shot infused with 25g of bioavailable protein and Goodnight™, a proprietary 2.5 fl oz shot targeted at the rapidly expanding $521m US sleep and relaxation category (Zenith International 1/20/11) and COLDsense™, a natural cold and flu remedy into the $2.6b US Cold/Allergy/Sinus tablet market (SymphonyIRI Group, Inc 9/5/10).

Blue Gold Beverages, Inc. is a leading high end producer of private label water and specialty beverages in North America. Some of our products include all natural sodas, teas, non-alcoholic wine coolers and energy drinks. Blue Gold Beverages head office situated in Montreal, Quebec, Canada, we use 3rd party bottling plants strategically located across North America depending on the geographical location of our clients. With the recent acquisition of TY Recycling, Blue Gold Beverages has entered into the polymer recycling business, selling PET and Nylon waste. This is in-line with the company's strategy of becoming environmentally responsible by eliminating its carbon footprint, and increasing shareholder value.

On average, the human brain weights 1.4 Kilograms (about 3 pounds). It is estimated that the brain consists of 85% water. The brain is extremely sensitive to water loss. It is said that the brain cannot tolerate even a 1% loss of water. If it were to be dehydrated to the point of being only 84% water for long, the brain would not function properly. (Remember that nerve cells in the brain are one-time-living units. They don't multiply like other cells in the body and don't regenerate). Dehydration can cause damage in the blood vessels in the brain, leading to bleedings and plaques, which are at the base of most neurological disorders like multiple sclerosis, Parkinson's disease and Alzheimer's disease.

For more information BGBV, please visit:
http://www.bluegoldbeverages.com

********************

Savvis, Inc. (NASDAQ:SVVS), a global leader in cloud infrastructure and hosted IT solutions for enterprises, is pleased to announced that it has won the Best Enterprise Solution Award at the 2011 Cloud Computing World Series Awards.

Savvis, Inc., is a global leader in cloud infrastructure and hosted IT solutions for enterprises. Nearly 2,500 unique clients, including more than 30 of the top 100 companies in the Fortune 500, use Savvis to reduce capital expense, improve service levels and harness the latest advances in cloud computing. For more information, please visit
www.savvis.com.

********************

WSFS Financial Corp. (Nasdaq:WSFS) announced the opening of a new banking office located at 5000 West Chester Pike in Newtown Square, PA 19073. The new Edgmont branch, WSFS Bank's fifth Pennsylvania location, is a full-service banking office and features extended banking hours, drive-up teller and ATM.

WSFS Financial Corporation operates as the thrift holding company for the Wilmington Savings Fund Society, FSB, which provides various financial services primarily in the mid-Atlantic region of the United States. The company was founded in 1832 and is headquartered in Wilmington, Delaware.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received seven thousand five hundred dollars ($7,500) in cash from a third party (9186 2780 Quebec Inc) for 1 week of media advertisement services for Blue Gold Beverages, Inc. (OTC:BGBV).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg